Sort
21,281 grants matching “influenza”
CENTER FOR RESEARCH ON STRUCTURAL BIOLOGY OF INFECTIOUS DISEASES: RESEARCH ON RESISTANT BACTERIA
$1,454,968Peter Myler · Seattle Children'S Hospital · N01 · FY2023 · AI
Screening Core
$1,453,428James Robert Bostwick · University Of Alabama At Birmingham · U19 · FY2016 · AI
MFB: Better Homologous Folding using Computational Linguistics and Deep Learning
$1,453,104Liang Huang · Oregon State University · · FY2024 · CSE
DYNAMICS OF INFLUENZA A VIRUS DEFECTIVE INTERFERING PARTICLE REPLICATION - FROM SINGLE CELLS AND TISSUES TO THE HOST LEVEL (DIA_TIP)
$1,452,771Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. · · FY2017 · Department of the Army
Innate inflammatory responses during pulmonary infections
$1,451,320Katrin Mayer-Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Protein-mediated membrane remodeling
$1,450,984Leonid V. Chernomordik · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2011 · HD
Self-administered microneedle patches for influenza vaccines
$1,450,383Richard W Compans · Emory University · U01 · FY2009 · AI
Toward a universal influenza virus vaccine based on live attenuated NS1-deleted influenza viruses
$1,450,070Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · AI
Discovery of adjuvants via novel modulation of innate immune pathways for vaccines against influenza
$1,449,134Aaron Esser-Kahn · University Of Chicago · N01 · FY2023 · AI
SARS-CoV-2-reactive tissue-resident memory T cells in healthy and cancer subjects
$1,446,305Pandurangan Vijayanand · La Jolla Institute For Immunology · U01 · FY2020 · CA
Influenza Viral Pathogenesis
$1,445,543Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Human Mab Cocktails to Prevent & Treat H5N1 Avian Influenza
$1,444,744Wayne A. Marasco · Dana-Farber Cancer Inst · U01 · FY2010 · AI
ADDRESSING EMERGING INFECTIOUS DISEASES IN THE REPUBLIC OF INDIA: INFLUENZA DISEA
$1,444,280Akilesh C Mishra · Indian Council Of Medical Research · U01 · FY2008 · IP
Effects of Vaccination on Acute and Post-Acute Respiratory Viral Infection Outcomes in Solid Organ Transplant Recipients
$1,442,898William Werbel · Johns Hopkins University · R01 · FY2025 · AI
Surveillance for Vaccine Preventable Disease in Children
$1,441,647Julie Anne Boom · Baylor College Of Medicine · U01 · FY2021 · IP
IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children
$1,441,647Rangaraj Selvarangan · Children'S Mercy Hosp (Kansas City, Mo) · U01 · FY2021 · IP
IP21-002, Enhanced Surveillance Network for Enteric and Respiratory Viruses in Children: Assessing Disease Burden, Natural History, and Vaccine Effectiveness
$1,441,647Geoffrey Alan Weinberg · University Of Rochester · U01 · FY2021 · IP
US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children
$1,441,646Mary A Staat · Cincinnati Childrens Hosp Med Ctr · U01 · FY2021 · IP
IP21-002, Enhanced Surveillance to Assess Vaccine Preventable Enteric and Respiratory Virus Illnesses
$1,441,645Janet A Englund · Seattle Children'S Hospital · U01 · FY2021 · IP
Enhanced Surveillance for New Vaccine Preventable Diseases
$1,441,645Natasha Bassam Halasa · Vanderbilt University Medical Center · U01 · FY2021 · IP
New Strategies to Prevent Death from Influenza
$1,440,342Kendall A Smith · Weill Medical Coll Of Cornell Univ · U01 · FY2006 · AI
Genomic profiling of influenza infections to identify biomarkers of disease severity
$1,439,918Elodie Ghedin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Adaptation of Influenza Inhibition Assays for High-throughput Screening
$1,439,620James W Noah · Southern Research Institute · R01 · FY2006 · AI
Antigen Processing And Presentation In The Intestine
$1,438,892Brian Kelsall · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Adjuvant Enhanced Antiviral Immunity
$1,438,772Jeff C Fairman · Colby Pharmaceutical Company · U01 · FY2011 · AI